Send to a Friend Font Size: Increase Decrease

ARQT and PVLA Related Headlines

Sep 3, 2025 07:30AM Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

ARQT and PVLA Related Press Releases

Sep 3, 2025 07:30AM Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

ARQT and PVLA Related SEC Filings